Keeogo™ Obtains CE Marking - B-Temia's Keeogo™ Obtains CE Marking Allowing its Commercialization in EU Countries

B-TEMIA ASIA

B-Temia Inc. (the "Company"), a Canadian robotics tech company and leader in the human mobility market, announces today that it is now authorized by the notified body British Standard Institute (BSI) to affix the CE marking on its powered human mobility device Keeogo™. The CE marking opens new markets and allows the Company to commercialize Keeogo in the 28 European Union countries and facilitates its registration in some countries in Asia.

More information

Details

Quebec City, QC, Canada

B-Temia

Associated Trend items

B-TEMIA ASIA OBTAINS TAIWAN FOOD & DRUG ADMINISTRATION (TFDA) PRODUCT LICENSE

B-TEMIA ASIA

B-Temia Asia, a joint venture company between Wistron Medical Technology Company and B-Temia Inc. (the “Company”) incorporated in November 2019, announces today that it obtained the Taiwanese Food and Drug Administration (TFDA) product license for its powered human mobility device “Keeogo™. This license opens a new market and allows the Company to commercialize Keeogo™ ...

More information

B-TEMIA INC. OBTAINS 510(K) CLEARANCE FOR KEEOGO™ FROM THE USA FOOD & DRUG ADMINISTRATION (FDA

B-TEMIA ASIA

B-Temia Inc. (the “Company”) announces that it received 510(k) clearance from the United States Food and Drug Administration for its powered human mobility device Keeogo™ Dermoskeleton System. This clearance opens the largest medical device market in the world.

More information

Products associated

dual-leg rehabilitation exoskeleton

Compare

Remove all

Compare up to 10 products